Skip to content

The multicenter study to examine microsatellite instability (MSI) in advanced gastrointestinal and abdominal malignant tumor

The multicenter study to examine microsatellite instability (MSI) in advanced gastrointestinal and abdominal malignant tumor - The multicenter study to examine MSI in advanced gastrointestinal and abdominal malignant tumor (GI-SCREEN MSI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020437
Enrollment
3500
Registered
2016-01-05
Start date
2016-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal and abdominal malignant tumor

Interventions

None listed

Sponsors

Saitama Cancer Center National Cancer Center Hospital East
Lead Sponsor
MSD KK FALCO biosystems Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with histologically confirmed or clinically suspected advanced gastrointestinal or abdominal malignant tumor a: Colorectal cancer b: Gastric cancer c: Esophageal cancer d: Hepatocellular carcinoma e: Biliary tract cancer f: Pancreatic cancer g: Small intestine, Appendix or Anal canal cancer h: Neuroendocrine tumor or cancer of GI i: Gastrointestinal stromal tumor 2) Planned to receive systemic chemotherapy for malignant tumor 3) Presence or ability to acquire sufficient samples for MSI and/or MMR-IHC testing 4) Written informed consent was obtained

Exclusion criteria

Exclusion criteria: 1) Judged by the investigator to be inappropriate for study participation for any reason

Design outcomes

Primary

MeasureTime frame
The frequency of MSI-H in advanced gastrointestinal and abdominal malignant tumor

Secondary

MeasureTime frame
Association between MSI and MMR-IHC status and cancer genome alterations, molecular biological characteristics, clinicopathological features or prognosis

Countries

Japan

Contacts

Public ContactWataru Okamoto

National Cancer Center Hospital East Clinical Research Support Office

crc_msi_office@east.ncc.go.jp04-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026